Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJUU2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,504
Award facts
- Contract value 100% obligated
- $16,504.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,504 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and was awarded on November 28, 2025. This award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery will be performed at the company's headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system across diverse product categories including biologics, specialty pharmaceuticals, and medical consumables.
Quick answers
Who was awarded contract SPE2DR26FJUU2?
SPE2DR26FJUU2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FJUU2 worth?
The government has obligated $16,504 on SPE2DR26FJUU2.
Is contract SPE2DR26FJUU2 an order under another contract?
Yes. SPE2DR26FJUU2 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJUU2 competed?
The extent of competition for SPE2DR26FJUU2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award